Immediate Impact
1 by Nobel laureates 1 from Science/Nature 50 standout
Citing Papers
Siglecs as Immune Cell Checkpoints in Disease
2020 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Works of B Coiffier being referenced
Multicenter Phase II Trial of Immunotherapy With the Humanized Anti-CD22 Antibody, Epratuzumab, in Combination With Rituximab, in Refractory or Recurrent Non-Hodgkin's Lymphoma
2006
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.
1998
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| B Coiffier | 385 | 263 | 231 | 13 | 511 | |
| Greg Dueck | 458 | 219 | 332 | 13 | 550 | |
| T Papadaki | 259 | 204 | 156 | 13 | 435 | |
| Braylan Rc | 336 | 221 | 180 | 18 | 514 | |
| Viktoria Hjalmar | 338 | 324 | 122 | 13 | 530 | |
| Vera Vanhentenrijk | 369 | 212 | 239 | 13 | 563 | |
| Federica Quirini | 365 | 113 | 176 | 17 | 423 | |
| RJ Lukes | 282 | 237 | 129 | 10 | 433 | |
| Aruna Gowda | 261 | 220 | 230 | 15 | 512 | |
| I Bolz | 325 | 190 | 195 | 17 | 556 | |
| Aleš Obr | 355 | 118 | 366 | 20 | 460 |
All Works
Loading papers...